Fayolah Richards, PharmD

Articles by Fayolah Richards, PharmD

Insurer Costs of COVID-19 by Disease Severity and Duration

ByChantal E. Holy, PhD, MSc,Brandon J. Patterson, PhD,Jill W. Ruppenkamp, MSc,Fayolah Richards, PharmD,Ronita Debnath, BSc,Antoine C. El Khoury, PhD,Jessica K. DeMartino, PhD,Brahim Bookhart, MBA, MPH,Paul M. Coplan, PhD, MBA

March 4th 2024

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.

Health Care Costs of COVID-19 vs Influenza and Pneumonia

ByFayolah Richards, PharmD,Brandon J. Patterson, PhD,Jill W. Ruppenkamp, MSc,Ronita Debnath, BSc,Antoine C. El Khoury, PhD,Jessica K. DeMartino, PhD,Brahim Bookhart, MBA, MPH,Chantal E. Holy, PhD, MSc,Paul M. Coplan, PhD, MBA

October 12th 2023

COVID-19 health care costs are significantly greater than those for influenza and pneumonia. Treatment costs for severe COVID-19 exceed those for influenza and pneumonia by approximately $50,000.

Latest Updated Articles

Health Care Costs of COVID-19 vs Influenza and Pneumonia
October 12th 2023
Insurer Costs of COVID-19 by Disease Severity and Duration
March 4th 2024

Fayolah Richards, PharmD

Articles by Fayolah Richards, PharmD

Insurer Costs of COVID-19 by Disease Severity and Duration

Health Care Costs of COVID-19 vs Influenza and Pneumonia

Latest Updated Articles

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints

New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000

Community Oncology Must Adapt for CAR T, Bispecific Multiple Myeloma Care: Mohit Narang, MD

The Oncology Care Model: A Decade of Transformation